✦ LIBER ✦

Rofecoxib, valdecoxib and celecoxib increase risk of MI in rheumatic disease

Book ID: 120844967
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200716150-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rofecoxib: greater risk of MI and sudden

Rofecoxib: greater risk of MI and sudden cardiac death than celecoxib

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Rofecoxib and celecoxib users with prior

Rofecoxib and celecoxib users with prior MI at risk for another

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Rofecoxib, but not celecoxib, increases

Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study

✍ Bjorn Gudbjornsson; Sigurdur B. Thorsteinsson; Helgi Sigvaldason; Rannveig Einar 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 134 KB

HRT increases risk of heart disease, MI

HRT increases risk of heart disease, MI and death in diabetic women

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Projected risks and costs of cardiovascu

Projected risks and costs of cardiovascular disease due to increased systolic blood pressure associated with use of rofecoxib

✍ Mason W Russell; Jeffrey D Miller; Douglas C.A Taylor; Daniel M Huse 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB

More pronounced inhibition of cyclooxyge

More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib

✍ Burkhard Hinz; Harald Dormann; Kay Brune 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## Objective Recent findings suggest that permanent blockade of cyclooxygenase 2 (COX‐2) is one factor contributing to the cardiovascular side effects of selective COX‐2 inhibitors (coxibs) and nonsteroidal antiinflammatory drugs (NSAIDs). The present study compared the extent and time